LCD Reference Article Response To Comments Article

Response to Comments: Immune Globulin Intravenous (IVIg)

A54645

Expand All | Collapse All
Draft Article
Draft Articles are works in progress and not necessarily a reflection of the current billing and coding practices. Revisions to codes are carefully and thoroughly reviewed and are not intended to change the original intent of the LCD.

Document Note

Note History

Contractor Information

Article Information

General Information

Source Article ID
N/A
Article ID
A54645
Original ICD-9 Article ID
Not Applicable
Article Title
Response to Comments: Immune Globulin Intravenous (IVIg)
Article Type
Response to Comments
Original Effective Date
11/07/2015
Revision Effective Date
N/A
Revision Ending Date
N/A
Retirement Date
N/A

CPT codes, descriptions, and other data only are copyright 2023 American Medical Association. All Rights Reserved. Applicable FARS/HHSARS apply.

Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

Current Dental Terminology © 2023 American Dental Association. All rights reserved.

Copyright © 2024, the American Hospital Association, Chicago, Illinois. Reproduced with permission. No portion of the AHA copyrighted materials contained within this publication may be copied without the express written consent of the AHA. AHA copyrighted materials including the UB‐04 codes and descriptions may not be removed, copied, or utilized within any software, product, service, solution, or derivative work without the written consent of the AHA. If an entity wishes to utilize any AHA materials, please contact the AHA at 312‐893‐6816.

Making copies or utilizing the content of the UB‐04 Manual, including the codes and/or descriptions, for internal purposes, resale and/or to be used in any product or publication; creating any modified or derivative work of the UB‐04 Manual and/or codes and descriptions; and/or making any commercial use of UB‐04 Manual or any portion thereof, including the codes and/or descriptions, is only authorized with an express license from the American Hospital Association. The American Hospital Association (the "AHA") has not reviewed, and is not responsible for, the completeness or accuracy of any information contained in this material, nor was the AHA or any of its affiliates, involved in the preparation of this material, or the analysis of information provided in the material. The views and/or positions presented in the material do not necessarily represent the views of the AHA. CMS and its products and services are not endorsed by the AHA or any of its affiliates.

CMS National Coverage Policy

N/A

Article Guidance

Article Text
Noridian’s response to provider recommendations (for comment period ending 03/30/2015):

Response To Comments

Number Comment Response
1 One commenter suggested that it might be better to say” lymphoproliferative disease” or” lymphoproliferative diseases, including CLL” rather than using the term “CLL”. Occasionally, patients with other kinds of lymphoma developed significant hypogammaglobulinemia and infection. The ICD-9 diagnosis coding for lymphomas and related disorders was developed long before current lymphoma classifications using modern laboratory methods. Persons with these disorders who also have hypogammaglobulinemia and are prone to infections, should receive IVIG. Claims for IVIG for these patients might appropriately be coded with an ICD-9 code that describes their lymphoma AND an appropriate ICD-9 code for hypogammaglobulinemia such as 279.00 (hypogammaglobulinemia, unspecified). The presence of that latter code would allow payment under this LCD as issued in draft; however, the LCD finalized after ICD-10 implementation and the greater granularity of ICD-10 diagnosis codes provides singular diagnoses for this indication.
2 One commenter urged the expansion of “acceptable off-label uses for intravenous immune globulin (IVIg) in rare patient populations or in rare individual patient clinical scenarios” to include autoimmune retinopathy. Numerous references were also appended. We agree that many individuals with autoimmune retinopathy may benefit from infusions of intravenous immune globulins. The difficulty with regard to this policy is that there is no precise coding for that condition and the codes likely to be used are extremely non-specific. We have added language in the policy for this condition, but coverage will be handled as an “individual consideration”.
N/A

Coding Information

Bill Type Codes

Code Description

Please accept the License to see the codes.

N/A

Revenue Codes

Code Description

Please accept the License to see the codes.

N/A

CPT/HCPCS Codes

Please accept the License to see the codes.

N/A

CPT/HCPCS Modifiers

Group 1

Group 1 Paragraph

N/A

Group 1 Codes

N/A

N/A

ICD-10-CM Codes that Support Medical Necessity

Group 1

Group 1 Paragraph

N/A

Group 1 Codes

N/A

N/A

ICD-10-CM Codes that DO NOT Support Medical Necessity

Group 1

Group 1 Paragraph

N/A

Group 1 Codes

N/A

N/A

ICD-10-PCS Codes

Group 1

Group 1 Paragraph

N/A

Group 1 Codes

N/A

N/A

Additional ICD-10 Information

Bill Type Codes

Code Description

Please accept the License to see the codes.

N/A

Revenue Codes

Code Description

Please accept the License to see the codes.

N/A

Other Coding Information

Group 1

Group 1 Paragraph

N/A

Group 1 Codes

N/A

N/A

Coding Table Information

Excluded CPT/HCPCS Codes - Table Format
Code Descriptor Generic Name Descriptor Brand Name Exclusion Effective Date Exclusion End Date Reason for Exclusion
N/A N/A
N/A
Non-Excluded CPT/HCPCS Ended Codes - Table Format
Code Descriptor Generic Name Descriptor Brand Name Exclusion Effective Date Exclusion End Date Reason for Exclusion
N/A

Revision History Information

Revision History Date Revision History Number Revision History Explanation
N/A

Associated Documents

Medicare BPM Ch 15.50.2 SAD Determinations
Medicare BPM Ch 15.50.2
Related Local Coverage Documents
LCDs
L34314 - Immune Globulin Intravenous (IVIg)
Related National Coverage Documents
N/A
SAD Process URL 1
N/A
SAD Process URL 2
N/A
Statutory Requirements URLs
N/A
Rules and Regulations URLs
N/A
CMS Manual Explanations URLs
N/A
Other URLs
N/A
Public Versions
Updated On Effective Dates Status
09/01/2015 11/07/2015 - N/A Currently in Effect You are here

Keywords

  • Immune
  • Globulin
  • Intravenous
  • IVIg